Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q3 2022 Earnings

28JulConfirmed

Q4 2021

Q1 2022

Q2 2022

Q3 2022

-11.87

-10.5

-9.13

-7.77

Details

Expected EPS

-8.447800999999998

Actual EPS

-11.868383

Surprise EPS

-3.42

Surprise Percent

+40.49%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -11.868383 per share for Q3 2022.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.